MAP3K3通过TAL1/JAM-A通路促进髓状细胞透析,促进心肌缺血/再输损伤

Shiyu Hu1,2,3,4,5, Jian Zhang1,2,3,4,5, Jingpu Wang1,2,3,4,5

  • 1Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.

Theranostics
|December 8, 2025
PubMed
概括

骨髓细胞MAP3K3通过促进白细胞透症驱动心肌缺血/反损伤 (MI/RI) 的炎症. 用帕索帕尼布抑制MAP3K3可降低MI/RI严重程度和髓状细胞透,提供一种潜在的治疗策略.